|4Jul 15, 4:15 PM ET

Bharucha David 4

4 · Milestone Pharmaceuticals Inc. · Filed Jul 15, 2025

Insider Transaction Report

Form 4
Period: 2025-07-11
Bharucha David
Chief Medical Officer
Transactions
  • Award

    Common Shares

    2025-07-11+53,33363,333 total
  • Award

    Series B Common Warrants (right to buy)

    2025-07-11+53,33353,333 total
    Exercise: $1.88Exp: 2030-07-11Common Shares (53,333 underlying)
  • Award

    Series A Common Warrants (right to buy)

    2025-07-11+53,33353,333 total
    Exercise: $1.50Exp: 2026-07-11Common Shares (53,333 underlying)
Footnotes (2)
  • [F1]The reported securities are included within 53,333 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 53,333 shares of common stock.
  • [F2]Fully vested and exercisable.

Documents

1 file
  • 4
    form4-07152025_040715.xmlPrimary